Sih Partners, Lllp Acadia Pharmaceuticals Inc Transaction History
Sih Partners, Lllp
- $2.95 Trillion
- Q1 2025
A detailed history of Sih Partners, Lllp transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Sih Partners, Lllp holds 10,756 shares of ACAD stock, worth $239,858. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,756Holding current value
$239,858% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
351Shares Held
165MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$956 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$339 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$269 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$190 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$156 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.61B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...